A high-throughput pharmaceutical screen identifies compounds with specific toxicity against BRCA2-deficient tumors. (2010)
Attributed to:
The iBAC genomic DNA expression library
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-09-2434
PubMed Identifier: 20008842
Publication URI: http://europepmc.org/abstract/MED/20008842
Type: Journal Article/Review
Volume: 16
Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research
Issue: 1
ISSN: 1078-0432